Category: Blog
-
What Are the Three Stages Of Clinical Trials?
Clinical trials involve a series of studies that test the safety and effectiveness of drugs and other medical treatments. To ensure research is carried out thoroughly and safely, there are several different stages of clinical trials. In order to make sure the treatment is safe and effective for use in patients, it must successfully pass…
-
Types Of Signal In Pharmacovigilance
Pharmacovigilance is concerned with detecting the possible risks associated with a drug or treatment. Risks are monitored and assessed throughout the development and post-market phase. The aim of this is to determine the safety profile of the drug, identifying any potential adverse reactions and side effects that the drug may cause. Additionally, any beneficial reactions…
-
What’s the difference between Phase 2 and Phase 3 Clinical Trials?
In previous years, pharmacology and clinical trials were topics which mainly interested medical professionals, rather than the public. However, as a result of the COVID-19 pandemic, there has been a growing interest in clinical trials, alongside the development of the vaccine. As a global community, we have been able to see the development, testing, and…
-
What is Clinical Pharmacology and Therapeutics?
Clinical pharmacology and therapeutics is the science of medicines and how they are used to diagnose, prevent and treat diseases and disorders in humans. Clinical pharmacologists are experts in various aspects of medicinal treatment. They are able to determine the best medicine and dosage for an individual, based on a number of factors. They take…
-
Rare Disease Studies: A Guide to Research and Clinical Trials
Around 3.5 million people in the UK are living with a rare disease. Although each condition affects only a small number of people, there are thousands of rare diseases worldwide, many of which have limited research and no approved treatment. Continued investment in rare disease research and clinical trials is essential to improve diagnosis, develop…
-
Lending a Hand to Support Rare Disease Day
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from the official campaign suggestion of recreating the Rare Disease Day logo, our staff enthusiastically joined in to produce two canvases made from hundreds of individual handprints. The final recreation of the logo on one of…
-
Improving Patient Engagement In Clinical Trials To Develop New Drugs
Developing new drugs is a rigorous and detailed process, requiring close scrutiny and testing across clinical trials in order for the drug to successfully find its way to market. The development process is necessary for understanding drug safety and efficacy before it becomes available for public use. And with patients at the heart of clinical…
-
Challenges And Opportunities In Rare Disease Clinical Trials: Putting The Patient First
Clinical research helps develop new evidence-based approaches to treating health conditions, resulting in better, safer and more effective treatments. However, in the case of studying rare disease treatments, clinical research can be particularly challenging. This can be for a number of reasons, such as the rare disease not being fully understood, a lack of awareness…
